Investment will support commercial development in key markets, US and Europe Funding led by CITIC Securities Investment and supported by existing investor CN Innovations Headquarters relocated to larger premises in Cambridge Science Park, a leading UK life sciences hub Cambridge, UK: CN Bio Innovations (“CN Bio”), a leading cell culture company that has developed organ-on-chip laboratory […]
· Series B investment led by west-coast investor Foresite Capital, with all existing investors participating in the round · Funds will be used to accelerate development of the Company’s gene synthesis platform, through to introduction of first products CAMBRIDGE, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene […]
Investment will support commercial development in key markets, US and Europe Funding led by CITIC Securities Investment and supported by existing investor CN Innovations Headquarters relocated to larger premises in Cambridge Science Park, a leading UK life sciences hub Cambridge, UK: CN Bio Innovations (“CN Bio”), a leading cell culture company that has developed organ-on-chip laboratory […]
To develop and launch a kit dedicated to sample preparation for single-cell RNAsequencing Paris – Scipio bioscience, a Paris-based biotechnology company, developing a new generation of single-cell sequencing solutions, announces today that it has secured a €6.0 M Series A financing from an international syndicate led by M Ventures (Amsterdam, The Netherlands), the corporate venture […]
Arima Genomics, Inc., a company focused on research tools to accelerate the understanding of genome sequence and structure toward their role in human health and disease, announces that it has completed its Series A round of financing. Agilent Technologies, Inc. (NYSE: A) and Cowin Venture led this round, joined by Vectr Ventures and Berkeley Catalyst […]
RC2 platform simultaneously detects tens to thousands of RNA, DNA, proteins and therapeutic molecules at sub-cellular nanoscale 3D resolution in every cell throughout a tissue section, using spatial sequencing First applications are immuno-oncology, neuroscience, infectious disease, and a custom offering, to empower groundbreaking research projects through ReadCoor’s Select Release Program Cambridge, Mass. – ReadCoor, Inc., […]
Univercells, an innovative bioprocessing provider focused on increasing the availability of affordable biologics to address global health challenges, has announced up to EUR 50M financing from Gamma Biosciences, a new investment platform supported by leading global investment firm KKR, that is focused on next-generation bioprocessing technologies for the production of advanced biologic therapies including gene- […]
Paris ‐ Stilla Technologies, a leading provider of pioneering digital PCR (dPCR) solutions for high‐precision genetic analysis, has just raised €20 million ($22 million) in a Series B funding round that brought in a new investor, the Chinese group TUS‐Holdings, alongside the participation of existing investors Illumina Ventures, Kurma Partners, LBO France, Paris Saclay Seed […]
NEW YORK– Schrödinger, Inc. (the “Company”) (Nasdaq: SDGR), whose differentiated, physics-based software platform enables discovery of high-quality, novel molecules for drug development and materials applications, today announced the closing of its initial public offering of 13,664,704 shares of common stock at a public offering price of $17.00 per share, which includes 1,782,352 additional shares of […]
NEW YORK — Enzo Biochem, Inc. (NYSE:ENZ) (the “Company”) today disclosed that Harbert Discovery Fund, LP (“Harbert”) filed a lawsuit against the Company and the members of its board of directors (“Board”) in the U.S. District Court for the Southern District of New York. Enzo commented as follows: “We are disappointed but not surprised by […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
